Candida albicans: Cellular and Molecular Biology

1. Fungal infections John E Edwards1 and Priya Uppuluri2 UCLA David Geffen School of Medicine, USA. 1E-mail: jedwards@labiomed.org , 2E-mail: puppuluri@labiomed.org 2. Fungal infections- The South-Asian perspective Arunaloke Chakrabarti Division of Mycology, Postgraduate Institute of Medical Education & Research, Chandigarh, India. E-mail: arunaloke@gmail.com 3. Regulatory pathways during C. albicans infections Aaron P. Mitchell Mellon Institute, Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, USA. E-mail: apm1@andrew.cmu.edu 4. Virulence mechanisms and regulation Christophe D'Enfert Fungal Biology and Pathogenicity Unit - INRA USC2019, Department of Mycology, Institut Pasteur, Paris, France. E-mail: christophe.denfert@pasteur.fr
5. Signalling mechanisms in pathogenesis and virulence of C. albicans 6. Biofilm development by C. albicans David Andes Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison WI, USA. E-mail: dra@medicine.wisc.edu 7. Biofilm developme nt and resistance mechanisms by C. albicans Patrick Van Dijck1 and Mary-Ann Jabra Rizk2 1 VIB Department of Molecular Microbiology, KU Leuven, Kasteelpark, Arenberg, Leuven, Belgium. 2 University of Maryland School of Dentistry, Maryland, USA. 1E-mail: Patrick.VanDijck@mmbio.vib-kuleuven.be, 2E-mail: MRizk@umaryland.edu 8. Biofilm of C. albicans : development and regulation Ashraf S. Ibrahim1 and Priya Uppuluri2 9. Host immune responses during infections Gordon Brown The Institute of Medical Sciences, University of Aberdeen, Scotland. E-mail: gordon.brown@abdn.ac.uk 10. M echanism of drug resistance Dominique Sanglard Institute of Microbiology, University Hospital Lausanne and University Hospital Center, Lausanne, Switzerland. E-mail: Dominique.Sanglard@chuv.ch 11. Structure- function analyses of Multi-drug transporters Richard D. Cannon Department of Oral Sciences, University of Otago, Dunedin, New Zealand. E-mail: richard.cannon@otago.ac.nz 12. All about MFS multi-drug transporter of Candida albicans Rajendra Prasad1, Peer Abdul Haseeb Shah2 and Archana Redhu2 1Amity Institute of Integrative Sciences and Health and Amity Institute of Biotechnology, Amity University, Haryana, India. 2Membrane biology Labo ratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India. 1E-mail: rp47jnu@gmail.com, rprasad@ggn.amity.edu 13. Inhibitors/Modulators of MDR transporters Attilio Di Pietro Institute for the Biology and Chemistry of Protein, Lyon, France. E-mail : a.dipietro@ibcp.fr 14. Inhibitors/Modulators of MDR proteins/transporters Brian Monk Department of Oral Sciences, University of Otago, Dunedin, New Zealand. E-mail: brian.monk@otago.ac.nz 15. Anti-fungals
David Perlin Public Health Research Institute Center, New Jersey Medical School - Rutgers, The State University of New Jersey, New Jersey, USA. E-mail: perlinds@umdnj.edu 16. Anti-microbial peptides Joachim Ernst and Marc Swidergall Institut für Mikrobiologie, Molekulare Mykologie, Heinrich-Heine-Universität, D-40225 Düsseldorf, Germany. E-mail: Joachim.Ernst@uni-duesseldorf.de 17. Anti-candidial agents Slawomir Milewski Department of Pharmaceutical Technology and Biochemistry, Technical University of Gdansk, Poland. E-mail: slamilew@pg.gda.pl 18. MDR1 and its regulation Joachim Morschhäuser Institut für Molekulare Infektionsbiologie, Universität Würzburg, Würzburg, Germany. E-mail: joachim.morschhaeuser@uni-wuerzburg.de 19. Genomics and Anti-fungal resist ance
Kaustuv Sanyal Molecular Biology and Genetics Unit, Jawaharlal Nehru Centre for Advanced Scientific Research, Jakkur, Bangalore, India. E-mail: sanyal@jncasr.ac.in 20. Genomics and Anti-fungal resistance Judith Berman Dept. of Molecular Microbiology & Biotechnology, George Wise Faculty of Life Sciences, Tel Aviv University, Israel. E-mail: Jberman@post.tau.ac.il 21. Lipids and Multi-drug resistance in Candida albicans Rajendra Prasad1and Ashutosh Singh2 1Amity Ins